1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America OTC Drug and Dietary Supplement Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America OTC Drug and Dietary Supplement Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Growing Preference for Non-Prescription Drugs over Prescription Drugs
- 5.1.2 Growing prevalence of infectious diseases
5.2 Market Opportunities
- 5.2.1 R&D Activities by Market Players to Offer Improved OTC Drugs
5.4 Impact of Drivers and Restraints
6. North America OTC Drug and Dietary Supplement Market Regional Analysis
6.1 North America OTC Drug and Dietary Supplement Market Overview
6.2 North America OTC Drug and Dietary Supplement Market Revenue 2017-2027 (US$ Million)
6.3 North America OTC Drug and Dietary Supplement Market Forecast Analysis
7. North America OTC Drug and Dietary Supplement Market Analysis – by Product
7.1 Cough and Cold Products
- 7.1.1 Overview
- 7.1.2 Cough and Cold Products: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Vitamins and Dietary Supplements
- 7.2.1 Overview
- 7.2.2 Vitamins and Dietary Supplements: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Analgesics
- 7.3.1 Overview
- 7.3.2 Analgesics: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Gastrointestinal Products
- 7.4.1 Overview
- 7.4.2 Gastrointestinal Products: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Sleep Aids
- 7.5.1 Overview
- 7.5.2 Sleep Aids: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Oral Care Products
- 7.6.1 Overview
- 7.6.2 Oral Care Products: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Ophthalmic Products
- 7.7.1 Overview
- 7.7.2 Ophthalmic Products: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Antacids
- 7.8.1 Overview
- 7.8.2 Antacids: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Feminine Care
- 7.9.1 Overview
- 7.9.2 Feminine Care: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)
8. North America OTC Drug and Dietary Supplement Market Analysis – by Type
8.1 Branded and Generic
- 8.1.1 Overview
- 8.1.2 Branded and Generic: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
9. North America OTC Drug and Dietary Supplement Market Analysis – by Form
9.1 Tablets
- 9.1.1 Overview
- 9.1.2 Branded and Generic: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Capsules
- 9.2.1 Overview
- 9.2.2 Branded and Generic: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Powders
- 9.3.1 Overview
- 9.3.2 Branded and Generic: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Ointments
- 9.4.1 Overview
- 9.4.2 Branded and Generic: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Liquid
- 9.5.1 Overview
- 9.5.2 Branded and Generic: North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
10. North America OTC Drug and Dietary Supplement Market – North America Analysis
10.1 North America
- 10.1.1 North America OTC Drug and Dietary Supplement Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.1.1.1 North America OTC Drug and Dietary Supplement Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 US: North America OTC Drug and Dietary Supplement Market Breakdown, by Product
- 10.1.1.1.2 US: North America OTC Drug and Dietary Supplement Market Breakdown, by Type
- 10.1.1.1.3 US: North America OTC Drug and Dietary Supplement Market Breakdown, by Form
- 10.1.1.2 Canada:
North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.2.1 Canada: North America OTC Drug and Dietary Supplement Market Breakdown, by Product
- 10.1.1.2.2 Canada: North America OTC Drug and Dietary Supplement Market Breakdown, by Type
- 10.1.1.2.3 Canada: North America OTC Drug and Dietary Supplement Market Breakdown, by Form
- 10.1.1.3 Mexico :
North America OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.3.1 Mexico : North America OTC Drug and Dietary Supplement Market Breakdown, by Product
- 10.1.1.3.2 Mexico : North America OTC Drug and Dietary Supplement Market Breakdown, by Type
- 10.1.1.3.3 Mexico : North America OTC Drug and Dietary Supplement Market Breakdown, by Form
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America OTC Drug and Dietary Supplement Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 GlaxoSmithKline plc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Sanofi
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Johnson and Johnson Services, Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Abbott
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 AbbVie Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Bausch Health Companies Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Bayer AG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Procter & Gamble
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Novartis AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Reckitt Benckiser Group Plc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America OTC Drug and Dietary Supplement Market
